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Massive yet grossly underestimated global costs
of invasive insects
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Insects have presented human society with some of its greatest development challenges by
spreading diseases, consuming crops and damaging infrastructure. Despite the massive
human and ﬁnancial toll of invasive insects, cost estimates of their impacts remain sporadic,
spatially incomplete and of questionable quality. Here we compile a comprehensive database
of economic costs of invasive insects. Taking all reported goods and service estimates,
invasive insects cost a minimum of US$70.0 billion per year globally, while associated health
costs exceed US$6.9 billion per year. Total costs rise as the number of estimate increases,
although many of the worst costs have already been estimated (especially those related to
human health). A lack of dedicated studies, especially for reproducible goods and service
estimates, implies gross underestimation of global costs. Global warming as a consequence
of climate change, rising human population densities and intensifying international trade will
allow these costly insects to spread into new areas, but substantial savings could be achieved
by increasing surveillance, containment and public awareness.
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F
or millennia, insects have been responsible for spreading
devastating infectious diseases in both humans1 and
livestock2, ravaging crops and food stocks3, damaging
forests4, destroying infrastructure5, altering ecosystem
functions6 and weakening the resilience of ecosystems to other
disturbances7. This single invertebrate class (B2.5 million
species8) is therefore probably the costliest animal group to
human society.
A global challenge this century will be meeting the world’s food
requirements while maintaining economic productivity and
conserving biodiversity. Globally, insect pests have been reported
to reduce agricultural yields by 10–16% before harvest, and to
consume a similar amount following harvest9. In fact, the largest
food-producing countries, China and the United States, exhibit the
highest potential losses from invasive insects10. Several other insect
pests defoliate trees4 and degrade plant biodiversity, threaten
commercial forestry and hamper climate change mitigation via
increased tree mortality and associated increases in greenhouse-gas
emissions11. Many other insects are nuisance species or disease
vectors that directly erode public health—from the Seventeenth to
Twentieth centuries, insect-borne diseases caused more human
disease and death than all other causes combined12.
Insects are also among the most pervasive of invasive species.
For example, 87% of the B2,500 non-native terrestrial inverte-
brates in Europe are insects13. Yet, reliable estimates of their
impacts are difﬁcult to obtain, in particular for economic
assessments. Most cost estimates are disparate, regionally
focused, cover variable periods and are not always grounded in
veriﬁable data (see Methods). The types of costs also vary and
include both direct and indirect components (Fig. 1).
Consequently, extrapolating local costs to global scales is
challenging and few have attempted to overcome the many
inherent ﬂaws in this approach.
Reliable global cost summaries therefore remain a major
challenge. Indeed, there are currently only 86 insect species listed
in the International Union for Conservation of Nature (IUCN)
Global Invasive Species Database14, and of those there are no cost
estimates for 81.4%, while 12.8% of them have insufﬁcient
(unsourced) estimates. We therefore compiled the most compre-
hensive database of economic costs for invasive insects available to
date (737 screened articles, chapters and reports), standardizing
historical estimates as annual 2014 US dollars (US$; Methods).
We determined the reproducibility of each study’s cost
estimates by identifying the source of all values used to
extrapolate regional costs. When values were based on actual
measures as opposed to non-sourced estimates and had a clear
methodology provided, we deemed the resulting costs ‘reprodu-
cible’ (although we did not assess quality per se because of a lack
of standard, objective criteria to assess the accuracy of published
estimates; Methods). We categorized studies that did not meet
these criteria as ‘irreproducible’. We further divided all costs into
two main categories: ‘goods and services’ (including production
of agricultural and forestry goods, and cultural services; Fig. 1)
and ‘human health’, further splitting the former into agriculture,
forestry, infrastructure, mixed or urban categories, and the latter
into seven disease categories (Methods).
Taking all reported goods and services estimates, and avoiding
the extrapolation of limited data, invasive insects cost a minimum
of US$70.0 billion per year globally, while associated health costs
exceed US$6.9 billion per year. Total costs rise as the number of
estimates increases; therefore, the true costs of invasive insects to
human society are substantially larger (but by a currently
unquantiﬁable amount) than we report here. Further, future
costs are likely to increase as invasive insects expand their ranges
in response to climate change, as well as to increasing human
movements and international trade.
Results
Goods and services. We determined that invasive insects cost a
minimum of US$70.0 billion per year globally for goods and
services, of which US$25.2 billion per year comes from repro-
ducible studies (Fig. 2 and Supplementary Data 1). There was no
temporal pattern in annual cost rates (Supplementary Fig. 1), and
most estimates were direct measures (although estimated costs
were higher for extrapolated costs; see ‘Expenditure types and
targets’ in the Supplementary Methods and Supplementary
Fig. 2). Regionally, North America reported the highest annual
costs (4US$27.3 billion), followed by Europe (US$3.6 billion per
year; Fig. 2a,b), although this is likely more a function of the
intensity of research effort (see ‘Research effort’ below) rather
than a true reﬂection of relative regional costs. The 10 costliest
species change little whether including all or only reproducible
estimates (Fig. 2e,f).
According to a single study5, the most expensive insect is
purportedly the Formosan subterranean termite Coptotermes
formosanus estimated at 4US$30.2 billion per year globally
(Fig. 2e). However, that irreproducible estimate is based on a
single non-sourced value of US$2.2 billion per year for the United
States of America, a personal communication supporting a ratio
of 1:4 of control:repair costs in a single US city (New Orleans)
and an unvalidated assumption that the US costs represent
50% of the global total5. A more realistic ranking based on the
reproducible estimates only (Fig. 2f) places the diamondback
moth Plutella xylostella as the most expensive (US$4.6 billion per
year)15. Other costly insects include the brown spruce longhorn
beetle Tetropium fuscum (US$4.5 billion per year in Canada), the
gypsy moth Lymantria dispar (US$3.2 billion per year in North
America) and the Asian long-horned beetle Anoplophora
glabripennis (US$3.0 billion per year in North America and
Europe; Fig. 2f).
Human health. Global health costs directly attributable to inva-
sive insects exceed US$6.9 billion per year (Fig. 3); however, these
exclude malaria costs because that disease is not due to the
invasion of an insect vector throughout most of its distribution
(although malaria cases ‘imported’ into non-endemic areas do
incur treatment and prophylaxis costs16). Our summary also
excludes the economic impacts on productivity, income, tourism,
blood-supply system, personal protection and quality of life
(Supplementary Note 1), as well as historical epidemics of yellow
fever and dengue because no relevant cost estimates exist
(Methods). Most health-related estimates are a combination of
direct and indirect costs (79% and 93% for all estimates and
reproducible-only estimates, respectively; see Supplementary
Note 1), represent actual estimates as opposed to extrapolations
or model predictions (66% and 77%, respectively) and are
primarily related to medical care (75% and 88%, respectively; see
‘Expenditure types and targets’ in the Supplementary Methods
and Supplementary Figs 3 and 4). Dengue (from a virus
transmitted by Aedes albopictus and Ae. aegypti) costs represent
84% of total health costs, followed by 15% for West Nile virus
transmitted by Culex spp. (Fig. 3c,d). Asia (US$2.84 billion) and
North America (US$2.06 billion) and Central/South America
(US$1.85 billion) recorded the highest annual health costs
(Fig. 3a,b).
Research effort. The regional summaries for both goods and
services and health costs belie a strong positive relationship
between total costs and the number of individual estimates
(see ‘Sampling bias’ in the Supplementary Methods and Supple-
mentary Fig. 5). Across regions, goods and services costs increase
by 10 times for each additional 5.5 (reproducible-only) or
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13.0 (all) estimates (Supplementary Fig. 5a,b). This strong posi-
tive relationship remains when expressed across species
(Supplementary Fig. 6), but is necessarily more variable, given
that most species have only one cost estimate each. The same type
of relationship also exists for health costs, with total costs
increasing by 10 times for each additional 18.5–19.1 estimates
(Supplementary Fig. 6c,d). This regional bias in sampling corro-
borates the established phenomenon of a spatial mismatch
between invader impacts on threatened species and research
publications17, suggesting that large additional costs because of
invasive insects remain to be estimated in lesser-sampled regions
of the world, and reinforcing our hypothesis that the total costs
have been grossly underestimated.
Cumulative costs. Given that the regions to which these sums
apply do not have the same spatial area, have different climates,
have important crop and infrastructure differences, and are likely
to experience different insect invasion and detection probabilities,
extrapolating regional costs to correct for potential under-
sampling is dubious. We therefore expressed total costs and the
number of associated estimates as temporally cumulative values
to identify possible thresholds within the sampled regions and
categories (see ‘Sampling bias’ in the Supplementary Methods and
Fig. 4). For both global goods and services and human health
costs, there was evidence for an asymptote among the sampled
species based on ﬁtted logistic models (Fig. 4); however, repro-
ducible-only goods and services costs had more support for a
non-asymptotic linear model (Fig. 4b). This asymptotic behaviour
is driven principally by North American goods and services costs
(Supplementary Table 1 and Supplementary Fig. 7); in contrast,
asymptotic behaviour was more prevalent across compared
regions for human health costs (Supplementary Table 1 and
Supplementary Fig. 8). For human health costs dominated by
those associated with dengue fever, potential undersampling
appears less problematic than for clearly underestimated costs
from reproducible studies of goods and services. This variable
































































































































































































































Figure 1 | Market and non-market cost categories associated with invasive insect damages. Costs are subdivided into ‘goods and services’ (yellow) and
‘human health’ (red), ‘regulating services’ (sensu non-commercial, but potentially monetizable, such as carbon regulation and pollination not otherwise
quantiﬁed in agricultural yield estimates; blue) and ‘ecological’ costs (not typically monetizable; green). Owing mainly to a lack of monetary estimates, we
could not compile costs for the categories and subcategories coloured in grey. The inner circle (darkest colours) encapsulates costs associated with
prevention; the middle circle (mid-range colours) includes costs associated with damage from invasive insects; the outer circle (lightest colours) covers
costs associated with responses or follow-up to invasive insect incursions. The outermost purple arrow indicates the general increase in our ability to
estimate monetizable costs, and the direct relevance to human commerce and well being. DALY, disability-adjusted life year (lifespan lost because of
burden of insect-borne disease; not assessed).
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types demonstrate possible evidence of decelerating accumulation
rates (that is, the costliest insects are assessed initially, with
smaller damages estimated thereafter).
Discussion
The estimated total global costs, even after attempting to correct
for sampling bias, are therefore necessarily gross underestimates.
We found only 86 (goods and services) and 117 (health) estimates
globally, of which only 55% of the former (n¼ 47) and 85% of the
latter (n¼ 99) we deemed reproducible. Ecosystem-regulating
services, which have high economic value worldwide18, are
notoriously difﬁcult to estimate19; hence, estimating the cost of
their erosion arising from invasive insects is still unknown. In
fact, we identiﬁed only one study20 that provided reproducible
economic costs of the erosion of ecosystem-regulating services
(that is, costs not directly associated with goods and services or
health, such as the erosion of pollination; Fig. 1) because of
invasive insects (two Vespula wasps in New Zealand). That study
showed that damages arising mainly from reduced pollination are
comparable to the direct costs to goods and services (for example,
lost apicultural production and control) and are much higher
than associated health costs20.
While many non-native species are clearly beneﬁcial to human
society (Supplementary Fig. 9) by providing food, ﬁbre, ecosystem
services and even ecological beneﬁts (habitats and resources for
native species21; ex situ conservation22; increasing reproductive
success of native plants23), the net outcome from non-native
insects is strongly negative. This net outcome arises because most
invasive non-native insects are not directly consumed or used in
any way by humans, and their overall beneﬁts to society remain
limited24.
There are two main phenomena leading to an increased
frequency of introductions and potentially expanding distribu-
tions of the costliest insect invaders: international trade25 and
global warming9. Invasions and subsequent expansions are
exacerbated by rising human populations, movement, migra-




















































































































































































































































































































































Figure 2 | Goods and services costs associated with invasive insects. Direct goods and services costs are categorized by major region (a,b), type (c,d)
and by the 10 costliest insects (e,f). The ﬁrst column includes all estimates regardless of reproducibility (a,c,e), whereas the second only includes costs for
which estimates can be veriﬁed (‘reproducible’; b,d,f). All costs expressed as annual 2014 US dollars. Bracketed numbers in the x axis labels indicate the
number of estimates per category.
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international policies targeting invasive species26. Climate change
projections to 2050 also predict a net average increase of 18% in
the area of occurrence of current arthropod invaders27.
Given that available economic estimates are sporadic, spatially
incomplete (especially outside Europe and North America), of
variable reproducibility and are likely to increase as the planet
warms and international trade expands, we conclude that the
costs of invasive insects to human society are underestimated and
will escalate with time. The available data describe only the
costliest insects of mainly industrial and/or biosecurity concern,
and non-market costs are rarely estimated (but see Supple-
mentary Note 1), even though they can at times exceed market
costs (for example, for forest pests28). In contrast, summaries of
direct costs at the scale of the broader economy might not always
adequately capture the true net costs of invasive insects because
some investments can potentially lead to savings arising from
mitigation (for example, costs of purchasing pesticides resulting
in reduced damage from targeted pests). It is therefore difﬁcult to
estimate total costs from different values of direct and indirect
categories of invasive insects impacts; therefore, we recommend
that cost summaries always be reported by type and target
(for example, Supplementary Figs 2 and 3).
Effective, early response and vigilant biosecurity are often
cheaper (by up to 10 times for mosquito-borne disease29) than
waiting to pay for accrued damages4,9, although this might not
always be the case when prevention investment occurs long
before any impacts are experienced30. In the rare cases where
those responsible for novel invasions are identiﬁed, ‘polluter pays’
legislation has been proposed31. However, most costs appear to be
borne ultimately by individuals via out-of-pocket expenses32,
higher consumer prices and taxes to fund management31, thus
reinforcing the poverty-illness nexus33. In addition to improving
guidelines for estimating the full costs of invasive insects, vigilant
planning, public-awareness campaigns and community parti-
cipation could potentially relieve society of billions of dollars of
annual expense, and reduce the contribution of invasive insects to
human suffering.
Methods
Literature review. We began our review of the literature on the economic impacts
of invasive insects using the ISI Web of Science database with a speciﬁc search
string to identify relevant papers (see below). We then used the Web of Science’s
‘reﬁne’ function to restrict the studies identiﬁed to the relevant ﬁelds, yielding 488
sources from 1911 to January 2014. We analysed each source to reject irrelevant
papers and retained those containing economic estimates. We completed our
database with 267 relevant studies up to December 2015 (including grey literature)
opportunistically gathered. In total, we screened 737 sources, 470 of which were
relevant to the economic impacts of invasive insects and from which 158 yielded
useable economic estimates (Supplementary Data 1 and 2). When economic values
were cited from studies not already included in the database, we searched and
gathered papers, reports or chapters providing the initial estimates. For each value,
we extracted the estimation methodology, and spatial and temporal coverage
(full databases available in Supplementary Data 1 and 2). Owing to the diversity of
the methods reviewed, we classiﬁed the reproducibility of economic values as
‘reproducible’ or ‘irreproducible’ based on qualitative criteria because of the
diversity of methods reviewed (see ‘Determining cost estimate reproducibility’
below). We attributed ‘reproducible’ to values with demonstrated calculation
methodologies, including uncertainties, and with available original references.
‘Irreproducible’ values were those without calculation methodologies, uncertainty
estimates or unavailable original references (see ‘Determining cost estimate
reproducibility’ below). We expressed all costs in 2014 US$34. We averaged
multiple values (for example, to provide an annual average over a speciﬁed period)
or uncertainty ranges before conversion to 2014 US$. In many cases we deemed
some of the multiple estimates for the same invasive insect species/disease and
region as redundant (that is, generally older, obsolete, incomplete or irreproducible
estimates). If monetary costs were provided as a range, we used the median value
for each estimate. Detailed calculations for each estimate are available in
Supplementary Data 1 and 2.
For health costs, we limited the criteria for invasive vector-borne diseases and
their related vector mosquitoes following Juliano and Lounibos35, based on several
life-history traits such as desiccation-resistant eggs, development in small, human-
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Figure 3 | Human health costs associated with invasive insects. Direct human health costs are categorized by major region (a,b) and disease (c,d). The
ﬁrst column includes all estimates regardless of reproducibility (a,c), whereas the second only includes costs for which estimates can be veriﬁed
(‘reproducible’; b,d). All costs expressed as annual 2014 US dollars. Bracketed numbers in the x axis labels indicate the number of estimates per category.
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We added chikungunya and zika and excluded historical epidemics of yellow fever,
dengue and malaria in South America because no estimates of these exist. Most of
the economic estimates of invasive mosquito-borne diseases that we obtained
concerned dengue, while only a few concerned West Nile, chikungunya and zika
viruses (Fig. 3c,d), and we therefore considered the costs of these diseases to be
under-represented. For this reason, we could not evaluate the many costs of
epidemics (zika, chikungunya, yellow fever and dengue). Nor did we include
estimates of the contribution of each disease to disability-adjusted life years (Fig. 1)
because these rarely include associated ﬁnancial components. To estimate annual
health costs based on the outbreaks of particular diseases covering multiple years,
we calculated national outbreak frequencies (annual probabilities) of disease
epidemics arising from invasive insects (Supplementary Data 3).
Search criteria for constructing the costs databases. We searched on Web of
Science in February 2014 and extracted records from 1911 to January 2014. Our
search string was composed of three elements: ‘invasive’ AND ‘insects’ and
‘economic impacts’. For each element we used a range of synonyms widely found
in the literature. For example, for ‘invasive’ we used invasi*, invader, alien, exotic,
non-native, introduced, naturaliz*. For ‘insects’, we also speciﬁed the names of a
range of taxa that we identiﬁed a priori as having potentially important economic
impacts. In addition, the search string included exclusion terms to reject irrelevant
studies, for example, those related to medicine. We completed the search for
citations in Google Scholar and internal government reports.
Full search string: TS¼ (invasi* OR invader OR alien OR exotic OR non-native
OR introduced OR naturaliz*) AND TS¼ (insect* OR hymenoptera OR ant OR
coleoptera OR mosquito* OR lepidoptera OR diptera OR hemiptera OR
Anoplophora chinesis OR Anoplophora glabripennis OR Dendroctonus
ponderosae OR Diabrotica virgifera OR Harmonia axyridis OR Leptinotarsa
decemlineata OR Trogoderma granarium OR Aedes aegypti OR Aedes albopictus
OR Anopheles gambiae OR Ceratitis capitata OR Culex pipiens OR Culex
quinquefasciatus OR Liriomyza huidobrensis OR Aphis gossypii OR Bemisia tabaci
OR Linepithema humile OR Solenopsis invicta OR Vespa velutina OR Wasmania
auropunctata OR Cameraria ohridella OR Helicoverpa armigera OR Lymantria
dispar OR Plutella xylostella OR Spodoptera littoralis OR Frankliniella occidentalis
OR Coptotermes formosanus) AND TS¼ (economi* OR monetary OR dollar*)
NOT TS¼ (cancer* OR cardio* OR surg* OR carcin* OR engineer* OR operation
OR medic* OR rotation OR ovar* OR polynom* OR purif* OR respirat* OR
invasive technique).
Removing potential double counts. We made every effort to eliminate redundant
amounts from the monetary values we used to estimate cost sums. First, we
removed values that were obvious re-estimates of older values (with the more
recent estimates tending to be more reproducible than older ones; for example,
Supplementary Data 1, column E). We further separated costs into ‘extrapolation’
versus ‘actual estimate’ categories (columns G and H in Supplementary Data 1,
respectively). Further removing those estimates already deemed irreproducible
(column F), column I indicates with absolute certainty which estimates should be
retained to avoid any potential case of double counting (that is, species with
reproducible estimates that do not include both extrapolated and actual estimates).
The sum of estimates in column I ($22,629,029,314) versus our sum of the total
costs (US$25,166,603,981) reported in the main text is only 10.1%, which suggest
that even in the unlikely case of double counting, the bias is minimal, and well
within the margin of error expected for a sum of median cost rates across the globe.
It is essential to note that even if a species includes both extrapolations and actual
values, it does not necessarily equate to double counting because often the different
estimates apply to different regions of the insect’s distribution or different
economic components of their costs. However, this does not exclude the possibility
of double counting within the irreproducible category, simply because we cannot
verify how the estimates were derived to check for instances of potential double
counting.
Validity of annual cost rate metric. It is possible that the impact rate of any
invasive species will vary over time, with rates being initially low following original
establishment, and then increasing as the species expands its range and possibly
declining as hosts are eliminated or humans adapt to the invasion. Consequently, a
simple sum of rates from many species that invaded at different points in time might
not provide a practical measure of standardized costs. However, ascertaining the year
of invasion of all species we examined was impossible or suspect, given a lack of
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Figure 4 | Global cumulative costs due to invasive insects. Costs are expressed relative to the number of estimates for goods and services (a,b) and
human health-related (c,d) costs, and for all estimates (a,c) and reproducible-only estimates (b,d). For a given year t, we summed all values (costs and
number of estimates) up to t (see ‘Sampling bias’ in the Supplementary Methods for model ﬁtting and comparison methods). We ﬁtted linear, exponential,
logarithmic and logistic models to each curve to examine evidence for asymptotic behaviour (identiﬁed by the dominance of a logarithmic or logistic
model). For all categories except reproducible-only goods and services costs (b), the logistic model (curvilinear grey dashed lines) had the highest Akaike’s
information criterion (AIC) weights (wAICErelative model probability) and explained 496% of the deviance in the data (%DEEcoefﬁcient of
determination). For reproducible-only goods and services costs (b), the linear model (straight grey dashed line) had the highest wAIC, indicating that the
logistic asymptote was likely an underestimate. For each ﬁt, we also show the approximate asymptotic cost and the associated number of cumulative
estimates required to achieve the asymptote (red lines). See also Supplementary Figs 7 and 8 for accumulation curves expressed by region. All costs
expressed as 2014 US dollars.
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plotted the cost rates versus the applicable year (median or publishing year for most
goods and services estimates; initial year of reporting interval for human health
estimates) for the goods and services and human health estimates separately. The
subsequent bivariate plots (Supplementary Fig. 1) do not reveal any relationship with
time. We therefore consider the use of cost rates as an appropriate metric for
standardizing costs across species, regions and time intervals.
Determining cost estimate reproducibility. We determined the reliability of the
cost estimates given in each study by identifying the source of all the ﬁgures used to
extrapolate regional costs. When monetary values were based on available
calculation methodologies, traceable original references and clearly identiﬁed
uncertainties, we deemed the resulting ﬁnal costs to be ‘reproducible’. This
reproducibility is not an assessment of quality or realism of the estimation; rather,
it is a qualitative assessment of whether the initial values, assumptions and
methodology applied to obtain the monetary value can be fully understood
(and ideally repeated). Conversely, we deﬁned as ‘irreproducible’ any monetary
values that could not be fully traced, clearly understood or justiﬁed. Thus, we
deemed a monetary value to be irreproducible when it was not properly referenced,
was not traceable, was derived from a potentially subjective source (for example,
a personal communication or a web page with no supporting references), did not
have the full details of the calculations or did not provide a clear list of the
underlying assumptions. We assessed reproducibility for every monetary value we
found in the literature; hence, some values might be reproducible and others
irreproducible in the same study (for example, ref. 36).
We could not apply the criteria in the same way to all types of monetary values.
For example, assumptions and calculations are necessary when monetary values result
from extrapolations (for example, see the calculations in Table 3 of ref. 37 or the
values in ref. 38), but not when they are reports of raw expenses and costs (for
example, values reported in ref. 39). The attribution of reproducibility was therefore a
qualitative procedure speciﬁc to each monetary value. As a consequence, we
supported our choices with narrative details about each value in the database (see, for
example, ‘detailed notes’ worksheet in Supplementary Data 1).
The attribution of reproducibility to monetary estimates was clear in most
cases. For example, values provided in refs 28,37,38 were explained clearly with
respect to details, methodologies, assumptions and limits; therefore, we classiﬁed
them as ‘reproducible’. Conversely, values for Ae. albopictus were classiﬁed as
irreproducible in ref. 6 because they were associated to a reference on Anoplophora
glabripennis. Likewise, some values in ref. 7 were either non-sourced or were
associated with personal communications, and were thus deemed irreproducible.
However, in some cases, the attribution was less certain. For example, in several
cases we were not able to obtain the sources of the estimates, especially for
non-English sources; therefore, we conservatively decided to attribute irreprodu-
cibility to these (for example, the various values in ref. 8), although we acknowledge
that they might in fact be reproducible. In the case of raw reports of expenses and
costs, we generally classiﬁed values provided by ofﬁcial institutions as reproducible
(for example, those in ref. 4), and from uncertain sources such as personal
communications with no more details than the name (for example, those in ref. 8)
or from conferences (for example, those in ref. 9) as irreproducible.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles.
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